Raymond James Financial Inc. Invests $10.34 Million in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Raymond James Financial Inc. bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 544,506 shares of the medical instruments supplier’s stock, valued at approximately $10,335,000.

Several other large investors have also recently modified their holdings of the business. Nordea Investment Management AB boosted its position in shares of DENTSPLY SIRONA by 245.0% in the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock valued at $4,754,000 after acquiring an additional 178,639 shares during the period. JPMorgan Chase & Co. boosted its position in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after acquiring an additional 1,244,326 shares during the period. Bank of New York Mellon Corp boosted its position in shares of DENTSPLY SIRONA by 27.9% in the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after acquiring an additional 523,692 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of DENTSPLY SIRONA by 1.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock valued at $39,880,000 after acquiring an additional 35,360 shares during the period. Finally, Barclays PLC boosted its position in shares of DENTSPLY SIRONA by 21.8% in the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after acquiring an additional 54,920 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Down 0.3 %

XRAY stock opened at $15.56 on Friday. The company has a market capitalization of $3.10 billion, a PE ratio of -7.52, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a one year low of $14.78 and a one year high of $33.52. The company’s 50 day moving average price is $17.92 and its two-hundred day moving average price is $20.53. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.11%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.07%.

Insiders Place Their Bets

In other news, Director Gregory T. Lucier bought 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.52% of the company’s stock.

Analyst Upgrades and Downgrades

XRAY has been the subject of a number of analyst reports. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their price objective for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Evercore ISI reiterated an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Finally, Mizuho dropped their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Twelve investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.